65,437 trials
Brain Neoplasms
Primary: Objective Response Rates. Assessed With Cranial MRI — 78.6; 48.1 Percentage of participants with OR — p=0.019
Dentinal Sensitivity · Hypersensitivity
Primary: Adjusted Mean Change From Baseline in Tooth Hypersensivity to Air Stimuli Immediately Following Treatment — -0.42; -0.32 units on a scale — p=0.2294
Neuroendocrine Carcinoma
Primary: Net Change Relative to Baseline in Tumor Blood Flow — -0.44; -0.12; -0.60; -0.40 ml/min/100gm
Bowel Obstruction
Primary: Total Opioid Burden — 115.00; 56.76 mg — p=0.0251
Acetaminophen Metabolism · Acetaminophen Poisoning · Drug Metabolism by Excipients
Primary: Acetaminophen Metabolites — 2.411; 2.009 mcg.hr/ml
Polycystic Ovary Syndrome
Primary: Brachial Artery Flow-mediated Dilation (FMD) — 12.0; 9.8; 10.4; 10.2 % change in brachial artery diameter — p=0.58
Multiple Myeloma
Primary: Overall Response Rate (ORR): Number of Participants Who Are Responders (Had Stringent Complete Response [sCR], CR, Very Good Partial Response [VGPR] or Partial Response…
Autism · Attention Deficit Disorder With Hyperactivity
Primary: Mean Conners' Teacher ADHD Index T Score by Dose — 72.8; 63.1; 63.6; 61.5 Units on a scale (T-scores) — p==.001
Hodgkin Lymphoma
Primary: Event-free Survival Probability by Risk Group — 0.886; 0.844; 0.667; 0.793 probability of 5 yr. event free survival
Migraine Disorders
Primary: Pain Free at Two Hours — 40; 21 participants
Osteoarthritis
Primary: Number of Participants With a Reduction in Pain by the Scores. — 25 participants
Psoriasis
Primary: Psoriasis Area Severity Index. This Scale Ranges From 0-72, 0 Being no Disease, and 72 Being Most Severe. The Number of Patients Who Achieved 75% Improvement of Their…
Colorectal Cancer
Primary: Response Rate (Percentage of Participants With Partial or Complete Response) — 43 percentage of participants with response
Influenza
Primary: Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 3 Strains of Influenza Disease. — 45.3; 81.1; 116.4; 170.9 titers
Influenza · Influenza, Human
Primary: Number of Subjects With Any, Grade 3 and Related Solicited Local Symptoms — 8; 5; 1; 2 Subjects